Diffuse large B-cell lymphoma
M Martelli, AJM Ferreri, C Agostinelli, A Di Rocco… - Critical reviews in …, 2013 - Elsevier
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …
A tabulated summary of the FDG PET literature
SS Gambhir, J Czernin, J Schwimmer… - Journal of nuclear …, 2001 - Soc Nuclear Med
This special supplement to The Journal of Nuclear Medicine is a detailed tabulation of
literature on FDG PET in oncology (1993–June 2000), cardiology (1986–June 2000), and …
literature on FDG PET in oncology (1993–June 2000), cardiology (1986–June 2000), and …
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Background The efficacy of autologous stem-cell transplantation during the first remission in
patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate …
patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate …
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in …
ME Juweid, S Stroobants, OS Hoekstra… - Journal of clinical …, 2007 - ascopubs.org
Purpose To develop guidelines for performing and interpreting positron emission
tomography (PET) imaging for treatment assessment in patients with lymphoma both in …
tomography (PET) imaging for treatment assessment in patients with lymphoma both in …
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
GJ Kelloff, JM Hoffman, B Johnson, HI Scher… - Clinical Cancer …, 2005 - AACR
[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
M Hutchings, A Loft, M Hansen, LM Pedersen, T Buhl… - Blood, 2006 - ashpublications.org
Risk-adapted lymphoma treatment requires early and accurate assessment of prognosis.
This investigation prospectively assessed the value of positron emission tomography with 2 …
This investigation prospectively assessed the value of positron emission tomography with 2 …
Role of functional imaging in the management of lymphoma
BD Cheson - Journal of Clinical Oncology, 2011 - ascopubs.org
18-F-fluorodeoxyglucose (FDG)–positron emission tomography (PET), and more recently
PET/computed tomography (CT), is the most sensitive and specific imaging technique …
PET/computed tomography (CT), is the most sensitive and specific imaging technique …
Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma
CH Moskowitz, H Schöder… - Journal of clinical …, 2010 - ascopubs.org
Purpose In studies of diffuse large B-cell lymphoma, positron emission tomography with
[18F] fluorodeoxyglucose (FDG-PET) performed after two to four cycles of chemotherapy has …
[18F] fluorodeoxyglucose (FDG-PET) performed after two to four cycles of chemotherapy has …
Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis
C Lin, E Itti, C Haioun, Y Petegnief… - Journal of Nuclear …, 2007 - Soc Nuclear Med
The purpose of this study was to assess the prognostic value of early 18F-FDG PET using
standardized uptake value (SUV) compared with visual analysis in patients with diffuse large …
standardized uptake value (SUV) compared with visual analysis in patients with diffuse large …
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome
C Haioun, E Itti, A Rahmouni, P Brice, JD Rain… - Blood, 2005 - ashpublications.org
Assessment of early therapeutic response using metabolic imaging is potentially useful to
determine prognosis in aggressive lymphoma. Between January 2000 and January 2004 …
determine prognosis in aggressive lymphoma. Between January 2000 and January 2004 …